CpG oligodeoxyribonucleotide 7909 enhances radiosensitivity via downregulating Oct-4 expression in radioresistant lung cancer cells

References

• AllemaniCWeirHKCarreiraHCONCORD Working GroupGlobal surveillance of cancer survival 1995–2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2)Lancet20143859972977101025467588
   PubMed Web of Science ®Google Scholar
• KimJJTannockIFRepopulation of cancer cells during therapy: an important cause of treatment failureNat Rev Cancer20055751652515965493
   PubMed Web of Science ®Google Scholar
• NiwaHMiyazakiJSmithAGQuantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cellsNat Genet200024437237610742100
   PubMed Web of Science ®Google Scholar
• BabaieYHerwigRGreberBAnalysis of Oct4-dependent transcriptional networks regulating self-renewal and pluripotency in human embryonic stem cellsStem Cells200725250051017068183
   PubMed Web of Science ®Google Scholar
• LiuCGLuYWangBBClinical implications of stem cell gene Oct-4 expression in breast cancerAnn Surg201125361165117121394007
   PubMed Web of Science ®Google Scholar
• AtlasiYMowlaSJZiaeeSABahramiAROCT-4, an embryonic stem cell marker, is highly expressed in bladder cancerInt J Cancer200712071598160217205510
   PubMed Web of Science ®Google Scholar
• WenKFuZWuXFengJChenWQianJOct-4 is required for an antiapoptotic behavior of chemoresistant colorectal cancer cells enriched for cancer stem cells: effects associated with STAT3/SurvivinCancer Lett20133331566523340171
   PubMed Web of Science ®Google Scholar
• KimKRoJYKimSChoYMExpression of stem-cell markers OCT-4 and CD133: important prognostic factors in papillary renal cell carcinomaHum Pathol201243122109211622944295
   PubMed Web of Science ®Google Scholar
• ChenZWangTCaiLClinicopathological significance of non-small cell lung cancer with high prevalence of Oct-4 tumor cellsJ Exp Clin Cancer Res2012311022300949
   PubMed Web of Science ®Google Scholar
• ChenYCHsuHSChenYWOct-4 expression maintained cancer stem-like properties in lung cancer-derived CD133-positive cellsPLoS One200837e263718612434
   PubMed Web of Science ®Google Scholar
• HuTLiuSBreiterDRWangFTangYSunSOctamer 4 small interfering RNA results in cancer stem cell-like cell apoptosisCancer Res200868166533654018701476
   PubMed Web of Science ®Google Scholar
• KumarSMLiuSLuHAcquired cancer stem cell phenotypes through Oct4-mediated dedifferentiationOncogene201231474898491122286766
   PubMed Web of Science ®Google Scholar
• WangDLuPZhangHOct-4 and Nanog promote the epithelial-mesenchymal transition of breast cancer stem cells and are associated with poor prognosis in breast cancer patientsOncotarget2014521108031081525301732
   PubMedGoogle Scholar
• ChiouSHWangMLChouYTCoexpression of Oct4 and Nanog enhances malignancy in lung adenocarcinoma by inducing cancer stem cell-like properties and epithelial-mesenchymal transdifferentiationCancer Res20107024104331044421159654
   PubMed Web of Science ®Google Scholar
• HuangPChenJWangLImplications of transcriptional factor, OCT-4, in human bladder malignancy and tumor recurrenceMed Oncol201229282983421533858
   PubMed Web of Science ®Google Scholar
• VollmerJKriegAMImmunotherapeutic applications of CpG oligodeoxynucleotide TLR9 agonistsAdv Drug Deliv Rev200961319520419211030
   PubMed Web of Science ®Google Scholar
• HemmiHTakeuchiOKawaiTA toll-like receptor recognizes bacterial DNANature2000408681374074511130078
   PubMed Web of Science ®Google Scholar
• BauerSKirschningCJHäckerHHuman TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognitionProc Natl Acad Sci U S A200198169237924211470918
   PubMed Web of Science ®Google Scholar
• CornélieSHoebekeJSchachtAMDirect evidence that toll-like receptor 9 (TLR9) functionally binds plasmid DNA by specific cytosine-phosphate-guanine motif recognitionJ Biol Chem200427915151241512914736866
   PubMed Web of Science ®Google Scholar
• LatzESchoenemeyerAVisintinATLR9 signals after translocating from the ER to CpG DNA in the lysosomeNat Immunol20045219019814716310
   PubMed Web of Science ®Google Scholar
• HoltickUScheulenMEvon Bergwelt-BaildonMSWeihrauchMRToll-like receptor 9 agonists as cancer therapeuticsExpert Opin Investig Drugs2011203361372
   PubMed Web of Science ®Google Scholar
• LiRSongYChenWEnhancing radiosensitivity of human pulmonary adenocarcinoma cell line A549 by CpG ODN1826Cancer Biother Radiopharm2011261697621355778
   PubMed Web of Science ®Google Scholar
• ZhaLQiaoTYuanSLeiLEnhancement of radiosensitivity by CpG-oligodeoxyribonucleotide-7909 in human non-small cell lung cancer A549 cellsCancer Biother Radiopharm201025216517020423229
   PubMed Web of Science ®Google Scholar
• YuanSQiaoTChenWCpG oligodeoxynucleotide 1826 enhances the Lewis lung cancer response to radiotherapy in murine tumorCancer Biother Radiopharm201126220320821539452
   PubMed Web of Science ®Google Scholar
• YanLXuGQiaoTChenWYuanSLiXCpG-ODN 7909 increases radiation sensitivity of radiation-resistant human lung adenocarcinoma cell line by overexpression of toll-like receptor 9Cancer Biother Radiopharm201328755956423705865
   PubMed Web of Science ®Google Scholar
• WitzigTEWisemanGAMaurerMJA phase I trial of immunostimulatory CpG 7909 oligodeoxynucleotide and 90 yttrium ibritumomab tiuxetan radioimmunotherapy for relapsed B-cell non-Hodgkin lymphomaAm J Hematol201388758959323619698
   PubMed Web of Science ®Google Scholar
• ShortSCGiampieriSWorkuMRad51 inhibition is an effective means of targeting DNA repair in glioma models and CD133+ tumor-derived cellsNeuro Oncol201113548749921363882
   PubMed Web of Science ®Google Scholar
• RuanMThornKLiuSThe secretion of IL-6 by CpG-ODN-treated cancer cells promotes T-cell immune responses partly through the TLR-9/AP-1 pathway in oral squamous cell carcinomaInt J Oncol20144462103211024676671
   PubMed Web of Science ®Google Scholar
• JarryUDonnouSVincentMTreg depletion followed by intracerebral CpG-ODN injection induce brain tumor rejectionJ Neuroimmunol20142671–2354224369298
   PubMed Web of Science ®Google Scholar
• XiaYGuptaGKCastanoAPMrozPAvciPHamblinMRCpG oligodeoxynucleotide as immune adjuvant enhances photodynamic therapy response in murine metastatic breast cancerJ Biophotonics2014711–1289790523922221
   PubMed Web of Science ®Google Scholar
• SorrentinoRMorelloSForteGB cells contribute to the antitumor activity of CpG-oligodeoxynucleotide in a mouse model of metastatic lung carcinomaAm J Respir Crit Care Med2011183101369137921278302
   PubMed Web of Science ®Google Scholar
• MellmanIFuchsRHeleniusAAcidification of the endocytic and exocytic pathwaysAnnu Rev Biochem1986556637002874766
   PubMed Web of Science ®Google Scholar
• RutzMMetzgerJGellertTToll-like receptor 9 binds single-stranded CpG-DNA in a sequence- and pH-dependent mannerEur J Immunol20043492541255015307186
   PubMed Web of Science ®Google Scholar
• FiolaSGosselinDTakadaKGosselinJTLR9 contributes to the recognition of EBV by primary monocytes and plasmacytoid dendritic cellsJ Immunol201018563620363120713890
   PubMed Web of Science ®Google Scholar
• KuznikABencinaMSvajgerUJerasMRozmanBJeralaRMechanism of endosomal TLR inhibition by antimalarial drugs and imidazoquinolinesJ Immunol201118684794480421398612
   PubMed Web of Science ®Google Scholar
• TillackKBreidenPMartinRSospedraMT lymphocyte priming by neutrophil extracellular traps links innate and adaptive immune responsesJ Immunol201218873150315922351936
   PubMed Web of Science ®Google Scholar
• SanjuanMARaoNLaiKTCpG-induced tyrosine phosphorylation occurs via a TLR9-independent mechanism and is required for cytokine secretionJ Cell Biol200617271057106816567503
   PubMed Web of Science ®Google Scholar
• PawlikTMKeyomarsiKRole of cell cycle in mediating sensitivity to radiotherapyInt J Radiat Oncol Biol Phys200459492894215234026
   PubMed Web of Science ®Google Scholar